Fierce Healthcare April 24, 2024
Paige Minemyer

UPDATED at 1 p.m. ET on April 24

Humana pulled back its growth projections for 2025 amid concerns about Medicare Advantage rates and demographic changes.

The company’s stock dropped out of the gate and was down by 4.5% as of 1:15 p.m. ET. Humana had originally estimated between $6 and $10 in earnings per share for 2025. Humana did confirm its conservative guidance for the year, and expects about $16 in earnings per share for 2024.

Earlier this month, the Centers for Medicare & Medicaid Services finalized a 0.16% decrease in the benchmark rate in Medicare Advantage despite significant pushback from the insurance industry. Chief Operating Officer Jim Rechtin warned on Humana’s earnings call Thursday that the changes would likely...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Medicare Advantage, Payer
How Quest pre-enrollment data can help your health plan serve members better
Cancer Patients Fighting Insurers: A Growing Trend
5 considerations for health plans evaluating the VOI of healthcare technology
Making Sense of the Federal Budget Process for Managed Care
Why Medicaid is the most innovative payer in healthcare | Viewpoint

Share This Article